Amgen Inc. ( AMGN) - Key Metrics
AMGN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $18.62 | $4.40 | $7.41 | $6.46 |
| 2026Q1 | $15.96 | $3.37 | $4.05 | $2.74 |
| 2025Q4 | $18.36 | $2.47 | $2.97 | $1.78 |
| 2025Q3 | $17.76 | $5.98 | $8.71 | $7.90 |
| 2025Q2 | $17.04 | $2.66 | $4.24 | $3.55 |
AMGN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 57.18% | 20.58 |
| 2026Q1 | 74.66% | 26.10 |
| 2025Q4 | 96.25% | 33.13 |
| 2025Q3 | 39.86% | 11.80 |
| 2025Q2 | 89.39% | 26.24 |
AMGN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.78% | 0.69% |
| 2026Q1 | 0.78% | 0.71% |
| 2025Q4 | 0.54% | 0.73% |
| 2025Q3 | 2.80% | 0.84% |
| 2025Q2 | 1.27% | 0.85% |
AMGN
Price: $443.84
Dividend Yield: 2.42%
Forward Dividend Yield: 2.29%
Payout Ratio: 155.17%
Dividend Per Share: 10.08 USD
Earnings Per Share: 16.11 USD
P/E Ratio: 25.51
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 1.7 million
Ebitda: 3.6 billionMarket Capitalization: 222.3 billion
Average Dividend Frequency: 4
Years Paying Dividends: 16
DGR3: 7.41%
DGR5: 8.50%
DGR10: 12.31%